Publications by authors named "Paul Solari"

Claim this Profile
H
Health care costs and resource use of managing hemophilia A: A targeted literature review.
Yilin Chen, Spencer J Cheng, Tyler Thornhill, Paul Solari, Sean D Sullivan

J Manag Care Spec Pharm· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resource utilization and treatment costs of patients with severe hemophilia A: Real-world data from the ATHNdataset.
Michael Recht, Chunla He, Er Chen, Dunlei Cheng, Paul Solari

EJHaem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care costs and resource utilization among commercially insured adult patients with hemophilia A managed with FVIII prophylaxis in the United States.
Courtney D Thornburg, Kelly Adamski, Keziah Cook, Mohini Vembusubramanian, Selvam R Sendhil, Paul Solari

J Manag Care Spec Pharm· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health insurance coverage and switching among people with hemophilia A in the United States.
Chunla He, David Hinds, Edmund Pezalla, Dunlei Cheng, Er Chen, Paul G Solari

J Manag Care Spec Pharm· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care resource utilization and costs among adult patients with hemophilia A on factor VIII prophylaxis: an administrative claims analysis.
Stacy E Croteau, Keziah Cook, Lamiya Sheikh, Anita Chawla, Joshua Sammon, Paul Solari

J Manag Care Spec Pharm· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare costs among patients with hemophilia A treated with factor replacement or bypassing agents.
Jason P Swindle, Yaping Xu, Yunming Mu, Paul G Solari

Curr Med Res Opin· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of an Algorithm for Identifying Patients with Hemophilia A in an Administrative Claims Database.
Jennifer Lyons, Vibha Desai, Yaping Xu, Greg Ridgeway, William Finkle, Paul Solari

Value Health· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO.
Bradley E Chipps, Robert S Zeiger, Allan T Luskin, William W Busse, Benjamin L Trzaskoma, Paul G Solari

Ann Allergy Asthma Immunol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Outcomes, Health Care Resource Use, and Costs Associated with High Versus Low HEDIS Asthma Medication Ratio.
Allan T Luskin, Evgeniya N Antonova, Michael S Broder, Eunice Chang, Karina Raimundo, Paul G Solari

J Manag Care Spec Pharm· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized multicenter study evaluating Xolair persistence of response after long-term therapy.
Dennis Ledford, William Busse, Benjamin Trzaskoma, Theodore A Omachi, Karin Rosén, Paul G Solari

J Allergy Clin Immunol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies.
James L Zazzali, Allen Kaplan, Marcus Maurer, Karina Raimundo, Benjamin Trzaskoma, Paul G Solari

Ann Allergy Asthma Immunol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab adherence in an observational study of patients with moderate to severe allergic asthma.
Susan L Janson, Paul G Solari, Benjamin Trzaskoma, Hubert Chen, Tmirah Haselkorn

Ann Allergy Asthma Immunol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of an ICD-9-based claims algorithm for identifying patients with chronic idiopathic/spontaneous urticaria.
Dasha Cherepanov, Karina Raimundo, Eunice Chang, Marianne Eagan, James L Zazzali, Paul G Solari

Ann Allergy Asthma Immunol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time asthma outreach reduces excessive short-acting β2-agonist use: a randomized study.
Robert S Zeiger, Michael Schatz, Qiaowu Li, Paul G Solari, James L Zazzali

J Allergy Clin Immunol Pract· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asthma quality-of-care measures using administrative data: identifying the optimal denominator.
Michael Schatz, Michael Broder, Eunice Chang, Richard O'Connor, Allan Luskin, Paul G Solari

Ann Allergy Asthma Immunol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triptan therapy impacts health and productivity.
Mary Brun Weaver, John I Mackowiak, Paul G Solari

J Occup Environ Med· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis